- Home
- AYTU vs CMBM Comparison
AYTU vs CMBM Comparison
Compare AYTU & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AYTU
- CMBM
- Stock Information
- Founded
- AYTU N/A
- CMBM 2011
- Country
- AYTU United States
- CMBM United States
- Employees
- AYTU N/A
- CMBM N/A
- Industry
- AYTU Biotechnology: Pharmaceutical Preparations
- CMBM Radio And Television Broadcasting And Communications Equipment
- Sector
- AYTU Health Care
- CMBM Technology
- Exchange
- AYTU Nasdaq
- CMBM Nasdaq
- Market Cap
- AYTU 19.7M
- CMBM 18.6M
- IPO Year
- AYTU N/A
- CMBM 2019
- Fundamental
- Price
- AYTU $2.36
- CMBM $0.72
- Analyst Decision
- AYTU Strong Buy
- CMBM Buy
- Analyst Count
- AYTU 2
- CMBM 1
- Target Price
- AYTU $10.00
- CMBM $3.00
- AVG Volume (30 Days)
- AYTU 77.6K
- CMBM 183.9K
- Earning Date
- AYTU 11-12-2025
- CMBM 11-06-2025
- Dividend Yield
- AYTU N/A
- CMBM N/A
- EPS Growth
- AYTU N/A
- CMBM N/A
- EPS
- AYTU N/A
- CMBM N/A
- Revenue
- AYTU $81,659,000.00
- CMBM $172,215,000.00
- Revenue This Year
- AYTU N/A
- CMBM N/A
- Revenue Next Year
- AYTU $2.00
- CMBM $17.73
- P/E Ratio
- AYTU $12.93
- CMBM N/A
- Revenue Growth
- AYTU 0.41
- CMBM N/A
- 52 Week Low
- AYTU $0.95
- CMBM $0.23
- 52 Week High
- AYTU $2.85
- CMBM $2.08
- Technical
- Relative Strength Index (RSI)
- AYTU 55.26
- CMBM 49.70
- Support Level
- AYTU $2.21
- CMBM $0.62
- Resistance Level
- AYTU $2.38
- CMBM $0.77
- Average True Range (ATR)
- AYTU 0.13
- CMBM 0.06
- MACD
- AYTU 0.01
- CMBM 0.00
- Stochastic Oscillator
- AYTU 73.08
- CMBM 42.19
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.